Structures by: Subasri S.
Total: 7
<i>N</i>-(4-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.2743(12)Å b=7.4835(5)Å c=19.8021(12)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.220(2)Å b=8.1180(12)Å c=19.628(2)Å
α=90° β=108.761(8)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(naphthalen-1-yl)acetamide
C16H15N5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=25.1895(16)Å b=6.9411(4)Å c=8.9697(6)Å
α=90° β=90.943(4)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-fluorophenyl)acetamide
C12H12FN5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=21.7358(7)Å b=7.3726(3)Å c=8.4487(3)Å
α=90° β=93.0920(10)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-nitrophenyl)acetamide monohydrate
C12H12N6O3S,H2O
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.23260(10)Å b=14.3442(2)Å c=14.0940(3)Å
α=90° β=90° γ=90°
<i>N</i>-(2-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.2528(2)Å b=7.6249(3)Å c=13.0649(4)Å
α=91.410(2)° β=105.924(2)° γ=94.647(2)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(2-methylphenyl)acetamide
C13H15N5OS
Acta Crystallographica Section E (2014) 70, 8 o850
a=22.782(5)Å b=7.144(5)Å c=8.857(5)Å
α=90.000° β=100.189(5)° γ=90.000°